August 28, 2016 4:52 AM ET

Biotechnology

Company Overview of Caladrius Biosciences, Inc.

Executive Profile

Christopher J. White M.D., FACC, FSCAI, FAHA, FESC

Member of Cardiovascular Disease Scientific Advisory Board, Caladrius Biosciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Christopher J. White, M.D., FACC, FSCAI, FAHA, FESC serves as Chairman, Department of Cardiology of the Ochsner Heart & Vascular Institute, Ochsner Medical Center in New Orleans. Dr. White's expertise includes non-surgical treatment of coronary and peripheral vascular diseases, including coronary stents, carotid stents, peripheral vascular angioplasty, laser therapy, valvuloplasty, brachytherapy, limb salvage, renal stents, and stroke therapy. He serves as a Director ...

Corporate Headquarters

106 Allen Road
Basking Ridge, New Jersey 07920

United States

Phone: 908-842-0100
Fax: --

Board Members Memberships

Director

Education

Unknown/Other Education
Case Western Reserve University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$597.6K
Robin C. Stracey Chief Executive Officer, President and Director
Cesca Therapeutics Inc.
$283.0K
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$450.0K
Neil K. Warma Chief Executive Officer, President, Acting Chief Financial Officer, Acting Principal Accounting Officer and Director
Opexa Therapeutics, Inc.
$416.6K
Andrey Semechkin Ph.D.Co-Chairman and Chief Executive Officer
International Stem Cell Corporation
$217.2K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Caladrius Biosciences, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.